James Rolke

REVB

James Rolke serves as Chief Executive Officer at Revelation Biosciences, Inc. (REVB). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$15.8K

Net Position

Net Seller

$15.8K

Companies Traded

REVB

Active Period

Feb 2026

1 total trades

Most Recent

Sell REVB

Feb 3, 2026 · $15.8K

James Rolke's Insider Trading at Revelation Biosciences, Inc. (REVB)

Buys

0 · $0.00

Sells

1 · $15.8K

Total Shares Bought

Total Shares Sold

8,521

REVB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 3, 2026	Sell	8,521	$1.86	$15.8K	0

Related Insiders

Chester Stanley Zygmont III

Chief Financial Officer

REVBSell · Feb 4, 2026

CARVER JENNIFER

Director

REVBSell · Feb 3, 2026

Lakhmir S Chawla

Director

REVBSell · Feb 3, 2026

ROPER JESS

Director

REVBSell · Feb 3, 2026

Explore More Insider Trading Data

REVB Insider Trading Activity

View all insider trades at Revelation Biosciences, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity